Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is looking at care and outcomes for people with Psychosis Associated With Alzheimer's Disease. Taking part may give some people access to KarXT, but direct benefit is not guaranteed.
This study is looking at care and outcomes for people with Lewy Body Dementia Psychosis. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is looking at care and outcomes for people with Psychosis Associated With Alzheimer's Disease. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is comparing MT1988 Low Dose with placebo for people with Clinical High Risk for Psychosis. Participants receive MT1988 Low Dose or placebo and complete study visits and assessments.
This observational study is following people with Alzheimer's Disease Psychosis to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This observational study is following people with Methamphetamine Use Disorder or Methamphetamine Induced Psychosis to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This observational study is following people with Methamphetamine Induced Psychosis to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
This study is looking at whether cognitive behavioural therapy can help people with Clinical High-Risk or Psychological. Participants take part in the program and complete follow-up questionnaires or assessments.
This study is looking at evaluate the feasibility and effectiveness of telehealth interventions for individuals at clinical high risk for psychosis (CHR). Participants take part in the program and complete follow-up questionnaires or assessments.
This study is comparing ITI-1284 with placebo for people with Psychosis Associated With Alzheimer's Disease. Participants receive ITI-1284 or placebo and complete study visits and assessments.
This observational study is following people with With Ultra High Risk of Psychotic Transition to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
This study is looking at whether Case management can help people with Psychotic Episode. Participants take part in Case management and complete follow-up assessments.
This study is looking at whether psychoeducation can help people with Caregiver, Caregiver Distress, Caregiver to a Young With Early Psychosis, or Family Caregivers. Participants take part in psychoeducation and complete follow-up assessments.
This study is looking at whether psychoeducation can help people with Clinical High Risk for Psychosis. Participants receive a study treatment and complete follow-up visits and assessments.
This study is comparing AGB101 with placebo for people with Parkinson Disease Psychosis. Participants receive AGB101 or placebo and complete study visits and assessments.
This study is looking at evaluate the effect of tDCS on psychotic-like symptoms in patients with Lewy Body Dementia (LBD) for people with Lewy Body Dementia, Lewy Body Dementia With Behavioral Disturbance, Burden, Caregiver, or Lewy Body Disease. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at culturally adapt and field test a manualised CBT intervention for young people at risk of first episode psychosis for people with Individuals at Risk of First Episode Psychosis. Participants take part in a digital support tool and complete follow-up assessments.
This study is looking at whether a digital support tool can help people with Parkinson's Disease Psychosis. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether Pimavanserin can help people with Neurodegenerative Diseases, Parkinson Disease, or Parkinson Disease Psychosis. Participants receive a study treatment and complete follow-up visits and assessments.
2 Deletion Syndrome to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at whether a mental health workshop can help people with severe mental illness. Participants receive advice and support from a mental health professional about oral health and daily oral hygiene.
This observational study is following people with Psychosis, depression, bipolar disease or Mental and Behavioural Disorders to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This observational study is following people with Treatment of catatonia in with unipolar depression, bipolarity or psychosis, that do not sufficiently benefit from treatment with lorazepam or Mental and Behavioural Disorders to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This observational study is following people with severe mental illness to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
This observational study is following people with Genetic, behavioural and environmental risk factors of metabolic syndrome in people treated with antipsychotics or Mental and Behavioural Disorders to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.